LESLIE HOUGHTON: Open Payments
NPI 1417134081 · NORTH MIAMI BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 17 payments from 11 companies in 2025. Trend: 2023 $1,025 · 2024 $523 · 2025 $434
Food & beverage: $434
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $139 |
| Gilead Sciences, Inc. | 2 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| PFIZER INC. | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Novo Nordisk Inc | 1 | $26 |
| Exact Sciences Corporation | 1 | $26 |
| Lilly USA, LLC | 1 | $23 |
| ABBVIE INC. | 1 | $21 |
| Dexcom, Inc. | 1 | $21 |
Products named: AIRSUPRA, FARXIGA, XIFAXAN, ELIQUIS, CAPVAXIVE, Ozempic, Cologuard Collection Kit, JARDIANCE.
Industry payments across FL — which companies pay providers there.
